A new study reveals ANKRD1 gene therapy improves memory in aged mice by enhancing neurogenesis, signaling potential for anti-aging treatments targeting brain health. ANKRD1 gene therapy boosts memory ...
Recent studies reveal complement system biomarkers, such as C3 and C4, change with age and correlate with dementia, offering potential for early Alzheimer’s detection and insights into immune sy...
Recent advancements in cellular reprogramming, including significant funding and clinical trials, are transforming anti-aging science by targeting root causes of age-related diseases. Cellular reprogr...
Recent studies show targeted epigenetic reprogramming with Yamanaka factors rejuvenates neurons, reversing cognitive decline in aged mice and reducing Alzheimer’s markers, with AI enhancing safe...
Recent studies show that targeting engrams with partial reprogramming factors improves memory in mouse models, offering a potential therapy for Alzheimer’s and age-related cognitive decline. New...
Recent studies reveal CAR-T cells with lecanemab antibodies reduce amyloid plaques in mice, highlighting a shift towards personalized cell-based therapies for Alzheimer’s treatment. New research...
Recent research identifies OTULIN as a key regulator of tau in neurons, offering a novel approach for Alzheimer’s disease by modulating production instead of clearance, with potential for person...
Recent studies confirm that 5,000-7,500 daily steps reduce cognitive decline in early Alzheimer’s by targeting tau pathology and enhancing brain waste clearance, per 2023 research. New research ...
Extracellular vesicles from stem cells offer a safer alternative to transplants for Alzheimer’s and Parkinson’s, reducing neuroinflammation and promoting repair with promising preclinical ...
Recent research reveals osteoarthritis patients face a 25% higher risk of neurodegenerative diseases due to chronic inflammation, with practical strategies like diet and exercise offering protection. ...
